Design and analysis of biomarker-integrated clinical trials with adaptive threshold detection and flexible patient enrichment

作者: Ting Wang , Xiaofei Wang , Stephen L George , Haibo Zhou

DOI: 10.1080/10543406.2020.1832110

关键词:

摘要: We propose a new adaptive threshold detection and enrichment design in which the biomarker is adaptively estimated updated by optimizing trade-off between size of positive population magnitude treatment effect that population. Enrichment based on an enrollment criterion accounts for uncertainty estimation threshold. Early termination futility allowed predictive success probability. Valid testing techniques overall inpatient subgroups are studied. Simulations example demonstrate advantages proposed over existing designs.

参考文章(18)
Guosheng Yin, Nan Chen, J. Jack Lee, Phase II trial design with Bayesian adaptive randomization and predictive probability Journal of the Royal Statistical Society: Series C (Applied Statistics). ,vol. 61, pp. 219- 235 ,(2012) , 10.1111/J.1467-9876.2011.01006.X
Donald R. Barr, E. Todd Sherrill, Mean and Variance of Truncated Normal Distributions The American Statistician. ,vol. 53, pp. 357- 361 ,(1999) , 10.1080/00031305.1999.10474490
Tze Leung Lai, Philip W. Lavori, Olivia Yueh-Wen Liao, Adaptive choice of patient subgroup for comparing two treatments Contemporary Clinical Trials. ,vol. 39, pp. 191- 200 ,(2014) , 10.1016/J.CCT.2014.09.001
Boris Freidlin, Wenyu Jiang, Richard Simon, The Cross-Validated Adaptive Signature Design Clinical Cancer Research. ,vol. 16, pp. 691- 698 ,(2010) , 10.1158/1078-0432.CCR-09-1357
Sumithra J. Mandrekar, Daniel J. Sargent, Clinical trial designs for predictive biomarker validation: Theoretical considerations and practical challenges Journal of Clinical Oncology. ,vol. 27, pp. 4027- 4034 ,(2009) , 10.1200/JCO.2009.22.3701
N. Simon, R. Simon, Adaptive enrichment designs for clinical trials Biostatistics. ,vol. 14, pp. 613- 625 ,(2013) , 10.1093/BIOSTATISTICS/KXT010
B. Freidlin, L. M. McShane, E. L. Korn, Randomized Clinical Trials With Biomarkers: Design Issues Journal of the National Cancer Institute. ,vol. 102, pp. 152- 160 ,(2010) , 10.1093/JNCI/DJP477
Peter Bauer, Frank Bretz, Vladimir Dragalin, Franz König, Gernot Wassmer, Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls Statistics in Medicine. ,vol. 35, pp. 325- 347 ,(2016) , 10.1002/SIM.6472